Research and Markets: Global Cancer Biomarkers Market Worth USD 15,973.8 Million by 2020 - Analysis, Trends, Technologies & Forecast 2015-2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/sqg99t/cancer_biomarkers) has announced the addition of the "Cancer Biomarkers Market by Tumor, Type, Profiling Technology, Application & Geography - Global Forecast to 2020" report to their offering.

The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.

This research report categorizes the cancer biomarkers market into the following segments:

Global Cancer Biomarkers Market, by Type:

  • Protein Biomarkers
  • Genetic Biomarkers
  • Others (Cell, Viral, and Carbohydrate Biomarkers)

Global Cancer Biomarkers Market, by Tumor Type:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others (Gastrointestinal Stromal Tumors (GIST), Lung, Ovarian, Bladder, Pancreatic, Kidney, Melanoma, and Leukemia)

Global Cancer Biomarkers Market, by Profiling Technologies:

  • Omics Technologies
  • Proteomics
  • Mass Spectrometry
  • 2D Gel Electrophoresis
  • Protein Microarray Technology
  • Antibody Array Technology
  • Peptide Array Technology
  • Genomics
  • Next Generation Sequencing (NGS)
  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Other Omics Technologies (Metabolomics and Glycomics)
  • Imaging Technologies
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Computed Tomography
  • Mammography
  • Ultrasound
  • Immunoassays
  • Immunohistochemistry (IHC) Tests
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
  • Cytogenetics-Based Tests
  • In Situ Hybridization
  • Others (Karyotyping, AmpliChip and In Vitro Diagnostic Multivariate Index Assays (IVDMIA))
  • Bioinformatics

Global Cancer Biomarkers Market, by Applications:

  • Diagnostics
  • Drug Discovery and Development
  • Prognostics
  • Risk Assessment
  • Others (Personalized Medicine, Surrogate Endpoints, Recurrence, and Therapeutics)

Companies Mentioned:

  • Abbott Laboratories
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Hologic Inc.
  • Illumina Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • Quest Diagnostics Inc.
  • Roche Diagnostics Ltd.

Report Structure:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 By Tumor Type

8 Cancer Biomarkers Market, By Type

9 By Profiling Technologies

10 By Application

11 By Geographic Analysis

12 Competitive Landscape

13 Company Profiles

14 Appendix

For more information visit http://www.researchandmarkets.com/research/sqg99t/cancer_biomarkers.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biomarkers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biomarkers